Drugs / autologous blood monocyte vesicles
autologous blood monocyte vesicles
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06707389 | Dec 2024 → Jun 2026 overdue | sensorineural hearing loss disorder, sudden hearing loss disorder | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous blood monocyte vesicles | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06707389 ↗ |
| Modality | Other / unclassified | “Extracellular vesicles therapy has been proved to be effective for several diseases.” NCT06707389 ↗ |
| Route | Other | “Intratympanic injection of autologous blood monocyte vesicles, three times a week.” NCT06707389 ↗ |